key: cord-0771610-uhjubcio
authors: Daher, Ghazal S.; Nassiri, Ashley M.; Vanichkachorn, Greg; Carlson, Matthew L.; Neff, Brian A.; Driscoll, Colin L.W.
title: New onset tinnitus in the absence of hearing changes following COVID-19 infection
date: 2021-09-10
journal: Am J Otolaryngol
DOI: 10.1016/j.amjoto.2021.103208
sha: 37424f688229d56bd5f6f5e898e8d1fb642aaaa2
doc_id: 771610
cord_uid: uhjubcio

BACKGROUND: A variety of neurosensory symptoms including tinnitus have been associated with COVID-19 infection. While most cases of tinnitus are associated with hearing loss, here we report a case of severe tinnitus following COVID-19 infection with normal thresholds through 8000 Hz. CASE REPORT: A 49-year-old male presented with new onset severe tinnitus following COVID-19 infection. Tinnitus was bilateral, constant and nonpulsatile. Audiometric evaluation revealed normal threshold through 8000 Hz, with mild hearing loss at 16,000 Hz. Conservative measures including masking strategies failed to mitigate symptoms. A trial of gabapentin 300 mg twice per day improved tinnitus with no notable side effects. CONCLUSION: This patient may represent a subpopulation of patients who suffer from severe tinnitus following COVID-19 infection in the setting of largely normal hearing. The pathophysiology may be distinct from the more common hearing loss associated tinnitus and perhaps neuromodulators may play a larger role in mitigating tinnitus in this patient subset.

Tinnitus affects up to 50 million adults in the United States, with 16 million experiencing chronic or frequent tinnitus. 1 Tinnitus is subjective and can have detrimental effects on mental health and quality of life. 2 Although majority of tinnitus cases are associated with hearing loss, up to 10% of cases occur in patients with no changes in hearing sensitivity on standard audiometric evaluation. 3 The current index patient and others suffering from COVID-19

infections brought forth two questions. First, does COVID-19 cause tinnitus? This important question can only be answered through careful data driven analysis and not anecdotal reports or case series. Second, is the pathophysiology of tinnitus related to COVID-19 different than that related to hearing loss? If so, then should we treat it differently?

The impact of COVID-19 infection on neurosensory systems is not well-understood; however, COVID-19 infection has been hypothesized to result in neurosensory dysfunction, most commonly in olfactory and gustatory alterations in up to 30% of affected patients. 4, 5 Tinnitus, vertigo, and sensorineural hearing loss occurring after COVID-19 infections have been reported; however, correlation and causation have not been determined. 6 Early studies reported new onset tinnitus after COVID-19 infection typically in conjunction with hearing loss. [7] [8] [9] Proposed mechanisms for audio-vestibular disorders coinciding with COVID-19 infection include direct cochlear and labyrinthine injury from persistent inflammatory cytokines within the inner ear, concomitant onset of an autoimmune response, direct viral invasion to nerves via ACE receptors, and ototoxicity of drugs used in COVID-19 patients such as hydroxychloroquine and macrolides. [10] [11] [12] In the present study, we report a unique case of severe, new onset tinnitus in a COVID-19 patient without significant hearing loss, which was successfully treated with gabapentin.

Journal Pre-proof

A 49-year-old male with past medical history of hyperlipidemia, and laboratory-confirmed COVID-19 infection three months prior, presented to our clinic tinnitus. The patient had a mild COVID-19 course and did not require hospitalization. His tinnitus developed shortly after his COVID-19 infection, and was bilateral, constant, and nonpulsatile. Specifically, he described a "high-pitched buzzing sound," which was constant throughout the day and most severe at night.

He had no history of tinnitus prior to this incident. Audiometric testing demonstrated normal thresholds through 8000 Hz, with mild hearing loss above 12.5k Hz (Figure 1 ). Tympanometry revealed normal tympanic membrane movement (type A), and word recognition scores using recorded isophonemic stimuli (20-word lists) were 100% bilaterally.

Initial treatment involved conservative measures such as white noise masking. Despite the conservative treatment strategies, education and time the tinnitus was persistent and significantly bothersome to the patient. Consequently, he was started on gabapentin 300 mg daily, which was tolerated well for two weeks and then titrated up to 300mg twice per day. Upon titrating to the more frequent dosing schedule, the patient's tinnitus symptoms significantly improved within two weeks on starting the medication, and while he continued to have tinnitus, it had reduced to an acceptable level. He did not experience any adverse side effects from the medication. His tinnitus continued to be improved for a one month follow up length.

The patient highlighted in this study may represent a unique group of individuals presenting with new-onset severe tinnitus symptoms out of proportion with audiometric findings Tinnitus in the normal or mild hearing loss population has been previously reported, however, patients with normal hearing or mild hearing loss typically have milder tinnitus symptoms compared to those with more significant degrees of hearing loss. 17, 18 Interestingly, our patient with severe tinnitus does not follow this pattern; rather, this patient exhibits normal hearing thresholds through 8000 Hz, with mild hearing loss above 12.5k Hz. Although measurable hearing loss is typically present in 90% of tinnitus cases, recent studies discussing new-onset tinnitus following a COVID-19 infection may suggest that rates of tinnitus in patients with normal or mild hearing loss may be higher in this population. Ozecelik Korkmaz et al. Both studies, however, were limited by subjective hearing data, as neither reported audiometric testing results. One study reporting audiometric testing noted that two patients experiencing persistent tinnitus symptoms after COVID-19 infection demonstrated mild transient declines in pure tone thresholds with no subjective hearing loss, which may suggest that cochlear changes associated with hearing loss were not persistent in these cases. 21 While current research has no definitive explanation for patients who develop severe tinnitus without associated hearing loss or with mild hearing loss, several hypotheses are worth exploring. First, comorbid psychosocial factors, such as depression, may play a significant role in the development of or exacerbation of underlying tinnitus. 22 This may play a larger role more recently as social stressors may have been exaggerated by the pandemic. Alternatively, pathways associated with sensory gating, or the suppression of non-novel input, have been implicated in tinnitus development. 23 More specifically, normal hearing or mild hearing loss adults with tinnitus have been speculated to have greater difficulty in suppressing incoming electrophysiologic inputs; this may provide a mechanism for the development of tinnitus in the absence of significant cochlear injury, however, further work to demonstrate this association is required. The specific patient population with normal hearing or mild hearing loss with severe tinnitus may represent a unique patient population with a different underlying cause of tinnitus. Figure 1 : Audiometric testing revealed normal hearing thresholds through 8000 Hz, with mild bilateral hearing loss above 12.5k Hz. Tympanometry was normal, and word recognition scores were excellent bilaterally.

J o u r n a l P r e -p r o o f

Prevalence and characteristics of tinnitus among US adults

Tinnitus: causes and clinical management

A systematic review of the reporting of tinnitus prevalence and severity

Neurotropism of SARS-CoV-2 and its neuropathological alterations: Similarities with other coronaviruses

A Review of Neuro-Ophthalmological Manifestations of Human Coronavirus Infection

SARS-CoV-2 (COVID-19) and audio-vestibular disorders

Changes in Tinnitus Experiences During the COVID-19 Pandemic

Tinnitus and equilibrium disorders in COVID-19 patients: preliminary results

Otologic Manifestations After COVID-19 Vaccination: The House Ear Clinic Experience

Sensorineural hearing loss with macrolide antibiotics exposure: a meta-analysis of the association

Ototoxicity of topical azithromycin solutions in the guinea pig

Auditory Cinchonism in COVID Era

The Impact of COVID-19 and the Pandemic on Tinnitus: A Systematic Review

COVID-19 associated anxiety enhances tinnitus

Psychopathological dimensions of tinnitus and psychopharmacologic approaches in its treatment

Self-perceived general and ear-nosethroat symptoms related to the COVID-19 outbreak: a survey study during quarantine in Italy

Association between hearing status and tinnitus distress

A comparison of the severity of tinnitus in patients with and without hearing loss using the tinnitus functional index (TFI)

Otolaryngological manifestations of hospitalised patients with confirmed COVID-19 infection

Audiovestibular symptoms and sequelae in COVID-19 patients

Association of Tinnitus with Depression in a Normal Hearing Population

Normal hearing young adults with mild tinnitus: Reduced inhibition as measured through sensory gating

Analysis of Gabapentin's Efficacy in Tinnitus Treatment: A Systematic Review